ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846

A+| A| A-

High Cost, Low Efficiency Medicines

LATELY there has been an increasing trend of introducing new drugs at exorbitant costs. These drugs are basically molecular changes of older drugs. It is said that the Drug Controller of India (DCI) takes due care in introduction of new drugs. But from the following examples, one starts doubting the DCI intentions.

Dear reader,

To continue reading, become a subscriber.

Explore our attractive subscription offers.

Click here

Comments

(-) Hide

EPW looks forward to your comments. Please note that comments are moderated as per our comments policy. They may take some time to appear. A comment, if suitable, may be selected for publication in the Letters pages of EPW.

Back to Top